Modular Molecular Diagnostics Platform

An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.

Molecular diagnostics platform for nucleic acid detection and amplification-based testing. Enables identification of pathogens and genetic markers for infectious disease and other molecular-based diagnoses.

Automated platform for molecular diagnostics of infectious pathogens. Integrates nucleic acid extraction and amplification for rapid disease identification.

A low-cost point-of-care and at-home molecular diagnostic platform utilizing isothermal RT-LAMP and CRISPR-mediated detection without requiring sample purification steps.

Molecular analysis system for detection of nucleic acids and genetic material. Enables identification of pathogens, genetic mutations, and infectious agents at molecular level.

A microfluidics-based platform for conducting blood tests with significantly reduced sample volume requirements. The technology integrates fluid handling, reagent storage, and analysis capabilities within a compact disposable cartridge format.

Integrated molecular diagnostics platform providing oligonucleotide synthesis, validation, and custom kit development for life science research and clinical applications. The platform supports batch planning with consistent final yields and reduced reorder requirements.

A molecular detection technology platform designed for rapid and accurate genetic screening and diagnosis. The system focuses on identifying hereditary and genetic diseases with clinical applications in prenatal and pediatric care.

A molecular testing platform delivering sample-to-answer syndromic testing near the point of care. Enables rapid diagnosis of multiple pathogens from a single sample, reducing time to clinical decision-making.

A sample-to-answer molecular testing system designed for near-patient syndromic testing. The platform delivers rapid molecular diagnostics directly at the point of care, enabling healthcare professionals to obtain results quickly for improved clinical decision-making.

Laser-based diagnostic platform designed for rapid, multiplexed lateral flow testing with significantly reduced manufacturing costs. The technology provides sensitive and scalable point-of-care diagnostic capabilities for various clinical applications.

A diagnostic platform utilizing two-way lateral flow technology for point-of-care testing. It provides rapid detection capabilities with precise temperature control, diverse connectivity options, and automatic sample recognition for efficient clinical diagnostics.